drugset / Trial / NCT07322094

CATALINA-4: A Study to Investigate the Safety and Efficacy of TORL-1-23 With Chemotherapy Given Before Initial Surgery in Women With Advanced Stage Ovarian Cancer

NCT07322094

Phase 1/2 Recruiting 60 enrolled TORL Biotherapeutics, LLC
Non-randomizedParallel-groupOpen-labelTreatment

Summary

A Phase 1B/2 Study to Investigate the Safety and Efficacy of TORL-1-23 with Chemotherapy Given Before Initial Surgery in Women with Advanced Stage Ovarian Cancer

Timeline

Start
2025-12-10
Primary completion
2027-12
Completion
2028-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Carboplatin Small molecule
Subject Paclitaxel Small molecule
Subject TORL-1-23 Other / unclassified